TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells

Nephron - Experimental Nephrology

Volumn 107, Issue 2, 2007, Pages

  Nee, Larine ^a   Tuite, Niamh ^a   Ryan, Michael P ^a   McMorrow, Tara ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Glomerular basement membrane; Interleukin 1beta; Matrixmetalloproteinase 9; Proteinkinase C; Renal disease; Tissue inhibitor of metalloproteinase 1; Tumour necrosis factor alpha

Indexed keywords

GELATINASE B; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HL-60 CELLS; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 9; MESANGIAL CELLS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 35048835797     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108645     Document Type: Article

References (44)

1. Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J: Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 2000;165:5788-5797.
2. Davies M: The mesangial cell: a tissue culture view. Kidney Int 1994;45:320-327.
3. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318:1657-1666.
4. Yu XQ, Fan JM, Nikolic-Paterson DJ, Yang N, Mu W, Pichler R, Johnson RJ, Atkins RC, Lan HY: IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 1999;154:833-841.
5. Timoshanko JR, Kitching AR, Iwakura Y, Holdsworth SR, Tipping PG: Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J Am Soc Nephrol 2004;15:910-918.
6. Egido J, Gomez-Chiarri Ortiz A, Bustos C, Alonso J, Gomez-Guerrero C, Gomez-Garre D, Lopez-Armada MJ, Plaza J, Gonzalez E: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int Suppl 1993;39:S59-64.
7. Nathan CF: Secretory products of macrophages. J Clin Invest 1987;79:319-326.
8. Baud L, Fouqueray B, Philippe C, Amrani A: Tumor necrosis factor alpha and mesangial cells. Kidney Int 1992;41:600-603.
9. van Kooten C, van der Linde X, Woltman AM, van Es LA, Daha MR: Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells. Kidney Int 1999;56:41-51.
10. Johnson RJ, Lovett D, Lehrer RI, Couser WG, Klebanoff SJ: Role of oxidants and proteases in glomerular injury. Kidney Int 1994;45:352-359.
11. Catania JM, Chen G, Parrish AR: Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol 2007;292:F905-911.
12. Lenz O, Elliot SJ, Stetler-Stevenson WG: Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000;11:574-581.
13. Koide H, Nakamura T, Ebihara I, Tomino Y: Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. Am J Kidney Dis 1996;28:32-39.
14. Sanders JS, van Goor H, Hanemaaijer R, Kallenburg CGM, Stegeman CA: Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2004;19:1412-1419.
15. Ebihara I, Nakamura T, Shimada N, Koide H: Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998;32:544-550.
16. Liu BC, Zhang L, Lv LL, Wang YL, Liu CG, Zhang XL: Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am J Nephrol 2006;26:483-490.
17. Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, Werner MC, Shield CF, Werb Z, Kalluri R: Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med 2006;3:535-546.
18. Lutz J, Yao Y, Song E, Antus B, Hamar P, Liu S, Heeman U: Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation 2005;79:655-661.
19. Cheng S, Pollack AS, Mahimkar R, Olson JL, Lovett DH: Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006;20:1898-1900.
20. Eberhardt W, Schulze M, Engels C, Klasmeier E, Pfeilschifter J: Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. Mol Endocrinol 2002;16:1752-1766.
21. Martin J, Knowlden J, Davies M, Williams JD: Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 1994;46:877-885.
22. Sraer JD, Delarue F, Hagege J, Feunteun J, Pinet F, Nguyen G, Rondeau E: Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int 1996;49:267-270.
23. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
24. Schoecklmann HO, Rupprecht HD, Gauer S, Yao J, Sterzel RB: Mesangial cell-matrix interactions in glomerular inflammation. Kidney Blood Press Res 1996;19:184-190.
25. Urushihara M, Kagami S, Kuhara T, Tamaki T, Kuroda Y: Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant 2002;17:1189-1196.
26. Matsubara M, Girard MT, Kublin CL, Cintron C, Fini ME: Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 1991;147:425-439.
27. Borden P, Heller RA: Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997;7:159-178.
28. Baud L, Oudinet JP, Bens M, Noe L, Peraldi MN, Rondeau E, Etienne J, Ardallou R: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989;35:1111-1118.
29. Meller D, Li DQ, Tseng SC: Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci 2000;41:2922-2929.
30. Nee L, McMorrow T, Campbell E, Slattery C, Ryan MP: TNF-α and IL-1β-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int 2004;66:1376-1386.
31. Han YP, Nien YD, Garner WL: TNF-alpha induced protolytic activation of pro-MMP-9 by human skin is controlled by down-regulating TIMP-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 2002;277:27319- 27327.
32. Yao PM, Maitre B, Delacourt C, Buhler JM, Harf A, Lafuma C: Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha. Am J Physiol 1997;273:L866-874.
33. Young RE, Thompson RD, Nourshargh S: Divergent mechanisms of action of the inflammatory cytokine interleukin 1-β and tumour necrosis factor-α in mouse cremasteric venules. Brit Jour Pharm 2002;137:1237-1246.
34. Dangerfield JP, Wang S, Nourshargh S: Blockade of α6 integrin inhibits IL-1β- but not TNF-α-induced neutrophil transmigration in vivo. J Leukoc Biol 2005;77:159-165.
35. Kuiper S, Joosten LA, Bendele AM, Edwards CK 3rd, Arntz OJ, Helsen MM, Van de Loo FA, Van den Berg WB: Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 1998;10:690-702.
36. Ismair MG, Ries C, Lottspeich F, Zang C, Kolb HJ, Petrides PE: Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1. Leukemia 1998;12:1136-1143.
37. Hussain S, Assender JW, Bond M, Wong LF, Murphy D, Newby AC: Activation of protein kinase-C is essential for cytokine-induced metalloproteinase-1, -3 and -9 secretion from rabbit smooth muscle cells and inhibits proliferation. J Biol Chem 2002;277:27345-27352.
38. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invas Metast 1992;12:168-184.
39. Gum R, Wang H, Lengyel E, Juarez J, Boyd D: Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signalling cascades. Oncogene 1997;14:1481-1493.
40. Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D: FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 2002;293:1174-1182.
41. Bokemeyer D, Panek D, Kramer HJ, Lindemann M, Kitahara M, Boor P, Kerjaschki D, Trzaskos JM, Floege J, Ostendorf T: In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2002;13:1473-1480.
42. Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE: SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol 2000;279:L895-902.
43. Floege J, Johnson RJ, Couser WG: Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin Invest 1992;70:857-864.
44. Floege J: Glomerular remodelling: novel therapeutic approaches derived from the apparently chaotic growth factor network. Nephron 2002;91:582-587.